Ingevity Corporation
New York Stock ExchangeCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- David H. Li
- Full Time Employees
- 1,500
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- Address
- 4920 O'Hear Avenue North Charleston SC United States of America 29405
- IPO Date
- May 3, 2016
- CIK
- 0001653477
- Website
- ingevity.com
- Similar Companies
- Business
- Ingevity Corporation (NYSE: NGVT) manufactures and sells specialty chemicals, activated carbon products, and engineered polymers that purify, protect, and enhance industrial applications worldwide. Founded in 1964 and headquartered in North Charleston, South Carolina, the company operates through three main segments: Performance Materials, offering activated carbon for gasoline vapor emission control in automotive evaporative systems, air and water purification; Advanced Polymer Technologies, providing caprolactone polymers and engineered materials for automotive components, certified biodegradable bioplastics, industrial and consumer plastics enhancement; and Performance Chemicals, supplying emulsifiers, additives, surfactants, and pavement technologies for asphalt paving and infrastructure, oilfield applications, industrial specialties, adhesives, agrochemicals, coatings, elastomers, and pavement markings. Ingevity maintains manufacturing facilities across North America, Europe, and Asia, serving automotive, infrastructure, energy, and industrial markets with approximately 1,600 employees. Recent strategic changes include the announcement in early 2025 to explore divestiture of its Performance Chemicals Industrial Specialties product line and North Charleston crude tall oil refinery to focus on higher-margin specialties, with the sale expected to close by early 2026; expansion of its partnership with CHASM in November 2025 through a licensing agreement for carbon nanotube production to support EV battery materials in North America and Europe, building on a 2024 joint development pact; and ongoing portfolio repositioning with $84 million in cost savings realized in 2024 from Performance Chemicals actions, alongside revised 2025 guidance projecting net sales of $1.25 billion to $1.35 billion and adjusted EBITDA of $390 million to $410 million.
Company News
Ingevity CEO Dave Li and CFO Phil Platt to speak at 2026 Jefferies Global Industrials Conference
Canada Pension Plan Investment Board Makes New Investment in Ingevity Corporation $NGVT
Ingevity (NGVT) Down 0.6% Since Last Earnings Report: Can It Rebound?
Ingevity: Portfolio Simplification Reveals A High-Margin Regulatory Compounder
Why You Should Add Ingevity Stock to Your Portfolio Now
Ingevity included in TIME America's Best Companies 2026 list
NGVT Q2 Earnings Beat on Pricing, Mix and Higher Volumes
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
Ingevity Releases 2025 Sustainability Report, Highlights Performance and Impact
Ingevity Q2 Earnings Call Highlights
Bank of New York Mellon Corp Has $15.03 Million Stake in Ingevity Corporation $NGVT
Ingevity Corporation (NGVT) Q2 2026 Earnings Call Transcript
Ingevity (NGVT) Tops Q2 Earnings and Revenue Estimates
Ingevity reports second quarter 2026 financial results
NGVT's Evotherm P35 Gets German Approval for Warm-Mix Asphalt Use
Ingevity's Evotherm® P35 receives BASt approval in Germany
Ingevity Shares Rise 25% YTD: Can the Stock Sustain the Rally?
Ingevity CEO Dave Li and CFO Phillip Platt to speak at 2026 Wells Fargo Industrials & Materials Conference
Why Is Ingevity (NGVT) Down 10.8% Since Last Earnings Report?
Ingevity Q1 Earnings Call Highlights